Barclays Initiates Coverage On Aspen Aerogels with Overweight Rating, Announces Price Target of $27
Portfolio Pulse from Benzinga Newsdesk
Barclays has initiated coverage on Aspen Aerogels (NYSE:ASPN) with an Overweight rating and set a price target of $27.
August 06, 2024 | 12:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays has initiated coverage on Aspen Aerogels with an Overweight rating and set a price target of $27.
The Overweight rating and a price target of $27 from Barclays is a positive signal for investors, likely leading to increased investor interest and a potential short-term price increase for ASPN.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100